Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
MGNX's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: No Debt )
MGNX' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.73
MGNX's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 0.73 )
MGNX' s 10-Year Equity to Asset Range
Min: -0.26   Max: 0.73
Current: 0.73

-0.26
0.73
Interest Coverage No Debt
MGNX's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: No Debt )
MGNX' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

Z-Score: 5.89
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 0.63
MGNX's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 0.63 )
MGNX' s 10-Year Operating margin (%) Range
Min: 0.63   Max: 12.86
Current: 0.63

0.63
12.86
Net-margin (%) -0.45
MGNX's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -0.45 )
MGNX' s 10-Year Net-margin (%) Range
Min: -0.45   Max: 13.1
Current: -0.45

-0.45
13.1
ROE (%) -0.33
MGNX's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -0.33 )
MGNX' s 10-Year ROE (%) Range
Min: -0.33   Max: -0.33
Current: -0.33

ROA (%) -0.21
MGNX's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: -0.21 )
MGNX' s 10-Year ROA (%) Range
Min: -0.21   Max: 15.56
Current: -0.21

-0.21
15.56
ROC (Joel Greenblatt) (%) 7.27
MGNX's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 7.27 )
MGNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.27   Max: 251.07
Current: 7.27

7.27
251.07
» MGNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

MGNX Guru Trades in

MGNX Guru Trades in

Q4 2013

MGNX Guru Trades in Q4 2013

John Griffin 900,000 sh (New)
» More
Q1 2014

MGNX Guru Trades in Q1 2014

Steven Cohen 870,189 sh (New)
John Griffin 900,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with MGNX

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Griffin 2013-12-31 New Buy0.25%$21.82 - $28.48 $ 20.2-23%900000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Macrogenics Inc

Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC
According to GuruFocus list of three-year lows, Knowles Corporation, Macrogenics Inc., MiX Telematics Ltd. and Education Management Corp have all reached their three-year lows. Read more...

Ratios

vs
industry
vs
history
P/B 3.61
MGNX's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 3.61 )
MGNX' s 10-Year P/B Range
Min: 3.33   Max: 12.85
Current: 3.61

3.33
12.85
P/S 4.27
MGNX's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 4.27 )
MGNX' s 10-Year P/S Range
Min: 1.98   Max: 8.7
Current: 4.27

1.98
8.7
EV-to-EBIT 606.07
MGNX's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 606.07 )
MGNX' s 10-Year EV-to-EBIT Range
Min: 153.2   Max: 1229.9
Current: 606.07

153.2
1229.9
Current Ratio 6.89
MGNX's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 6.89 )
MGNX' s 10-Year Current Ratio Range
Min: 1.35   Max: 6.89
Current: 6.89

1.35
6.89
Quick Ratio 6.89
MGNX's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 6.89 )
MGNX' s 10-Year Quick Ratio Range
Min: 1.35   Max: 6.89
Current: 6.89

1.35
6.89

Valuation & Return

vs
industry
vs
history
Price/Net Cash 3.90
MGNX's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 3.90 )
MGNX' s 10-Year Price/Net Cash Range
Min: 5.39   Max: 9.94
Current: 3.9

5.39
9.94
Price/Net Current Asset Value 3.87
MGNX's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 3.87 )
MGNX' s 10-Year Price/Net Current Asset Value Range
Min: 5.35   Max: 9.73
Current: 3.87

5.35
9.73
Price/Tangible Book 3.61
MGNX's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 3.61 )
MGNX' s 10-Year Price/Tangible Book Range
Min: 5   Max: 8.76
Current: 3.61

5
8.76
Price/Median PS Value 1.06
MGNX's Price/Median PS Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 1.06 )
MGNX' s 10-Year Price/Median PS Value Range
Min: 0.46   Max: 1.46
Current: 1.06

0.46
1.46
Earnings Yield (Greenblatt) 0.20
MGNX's Earnings Yield (Greenblatt) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. MGNX: 0.20 )
MGNX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.7
Current: 0.2

0.1
0.7

Business Description

Industry: »
Compare: » details
Traded in other countries:M55.Germany
» More Articles for MGNX

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC May 27 2014 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Jul 28 2014
MACROGENICS INC Files SEC form 8-K, Other Events Jul 25 2014
MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients Jul 24 2014
Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A) Jul 22 2014
Coverage initiated on MacroGenics by Oppenheimer Jul 11 2014
MacroGenics Initiates Phase 1 Study of MGD006 for the Treatment of Acute Myeloid Leukemia Jun 19 2014
CMC Biologics and MacroGenics Enter into Process Validation and Clinical Manufacturing Agreement for... Jun 17 2014
MacroGenics: A Balanced Small Cap Bio With A Great Entry Level Opportunity Jun 11 2014
MACROGENICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 11 2014
[$$] MacroGenics Looks Immune to Downside Jun 10 2014
MacroGenics (MGNX) Worth Watching: Stock Up 5.1% May 30 2014
MACROGENICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... May 29 2014
3 Stocks Rising on Unusual Volume May 29 2014
MacroGenics management to meet with Leerink May 28 2014
Weekly 3-Year Low Highlights: KN, MGNX, MIXT, EDMC May 27 2014
MacroGenics, Takeda Enter Strategic Alliance to Develop DART May 27 2014
MacroGenics and Takeda Enter Strategic Alliance to Develop DART for Treatment of Autoimmune... May 27 2014
MACROGENICS INC Financials May 14 2014
MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference May 07 2014
MACROGENICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 06 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide